1999
DOI: 10.1006/jmcc.1999.1037
|View full text |Cite
|
Sign up to set email alerts
|

The Absence of Desmin Leads to Cardiomyocyte Hypertrophy and Cardiac Dilation with Compromised Systolic Function

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

5
117
1
30

Year Published

2000
2000
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 158 publications
(153 citation statements)
references
References 49 publications
5
117
1
30
Order By: Relevance
“…Furthermore, in animal models, null mutation of the desmin gene gives rise to ultrastructural defects in cardiac muscle [26], degeneration of cardiomyocytes, accumulation of macrophages, and fibrosis [27]. Mice lacking desmin develop cardiomyocyte hypertrophy and age-dependent loss of cardiac performance, with chamber dilatation and compromised systolic function resembling cardiomyopathy [28]. On the other hand, desmin rescue mice with cardiomyocyte-specific desmin expression display a wildtype cardiac phenotype [29].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Furthermore, in animal models, null mutation of the desmin gene gives rise to ultrastructural defects in cardiac muscle [26], degeneration of cardiomyocytes, accumulation of macrophages, and fibrosis [27]. Mice lacking desmin develop cardiomyocyte hypertrophy and age-dependent loss of cardiac performance, with chamber dilatation and compromised systolic function resembling cardiomyopathy [28]. On the other hand, desmin rescue mice with cardiomyocyte-specific desmin expression display a wildtype cardiac phenotype [29].…”
Section: Discussionmentioning
confidence: 99%
“…The present study did not ascertain the function of desmin in DCM and heart failure. Whereas this protein plays an essential role for cardiac integrity [22,[26][27][28][29]32], the consequences of desmin upregulation in DCM are still unknown. However, the inverse correlation between the amount of myocardial desmin and the ejection fraction in DCM patients [23] may establish desmin as a valuable myocardial marker for cardiac dysfunction.…”
Section: Discussionmentioning
confidence: 99%
“…7853-1) analysis was performed by Clontech (Clontech, San Diego, CA), using pools of three hearts of 4-month-old desmin-null and wild-type animals. Northern blots were performed as previously described 2 The samples were analyzed by SDS-PAGE, transferred to polyvinylidene difluoride membranes, and probed for decorin and osteopontin using the antibodies LF-113 and LF-123, respectively, in a 1:1000 dilution. The antibodies were kindly provided by Dr. Larry Fisher.…”
Section: Isolation Of Rna Differential Display Pcr Cdna Arrays Andmentioning
confidence: 99%
“…[1][2][3] Similarly, missense mutations of desmin have been identified in humans suffering from idiopathic dilated cardiomyopathy 4 as well as other more generalized myopathies with both skeletal and cardiac dysfunction. [5][6][7][8]9 The cellular and tissue pathology associated with cardiac dysfunction in desmin-null mice has been adequately addressed.…”
mentioning
confidence: 99%
“…Therefore, they may link myofibrils to the sarcolemma, organelles and neighboring myocytes (Granger and Lazarides, 1979;Holtzer et al, 1985;Milner et al, 2000;O'Neill et al, 2002) (see Clark et al, 2002 for review). In particular, intermediate filaments are thought to be involved in maintaining muscle stability as desmin-null mice exhibit a reduction of myofibril alignment, significant muscle degeneration and necrosis, and impaired force transmission (Milner et al, 1996;Li et al, 1997;Milner et al, 1999;Balogh et al, 2002). Exactly how the intermediate filaments assemble during development is not understood, although some require a specific subpopulation of microtubules -detyrosinated microtubules (Glu-MTs) -for their localization and integrity in some cell types (Gurland and Gundersen, 1995;Kreitzer et al, 1999).…”
mentioning
confidence: 99%